Skip to main content
TipRanks
Go Ultimate75% OFF

Edesa Biotech (EDSA) Ratios

339 Followers

Edesa Biotech Ratios

EDSA's free cash flow for Q3 2026 was $-3.05M. For the 2026 fiscal year, EDSA's free cash flow was decreased by $-7.00 and operating cash flow was $-3.05M. See a summary of the company’s cash flow.

Financial ratios
RatiosSep 25Sep 24Sep 23Sep 22Sep 21
Liquidity Ratios
Current Ratio10.670.913.534.258.29
Quick Ratio10.670.913.534.258.29
Cash Ratio10.010.572.943.315.37
Solvency Ratio-6.55-3.26-4.45-7.98-8.66
Operating Cash Flow Ratio-6.79-2.67-3.64-5.74-9.37
Short-Term Operating Cash Flow Coverage0.000.000.00-647.130.00
Net Current Asset Value$ 10.43M$ -157.21K$ 4.60M$ 6.91M$ 10.56M
Leverage Ratios
Debt-to-Assets Ratio0.000.010.010.000.01
Debt-to-Equity Ratio0.000.010.010.000.01
Debt-to-Capital Ratio0.000.010.010.000.01
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.091.931.261.231.12
Debt Service Coverage Ratio0.000.000.00-918.620.00
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.000.010.030.010.06
Net Debt to EBITDA1.530.170.640.410.59
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT100.01%100.01%100.01%100.00%100.01%
EBT Per EBIT90.81%87.95%90.79%95.52%56.34%
Return on Assets (ROA)-53.11%-161.77%-94.20%-151.60%-91.49%
Return on Equity (ROE)-57.71%-311.44%-118.81%-186.86%-102.18%
Return on Capital Employed (ROCE)-63.54%-354.07%-130.48%-194.71%-180.42%
Return on Invested Capital (ROIC)-63.54%-350.56%-129.11%-193.93%-179.34%
Return on Tangible Assets-62.20%-355.59%-124.80%-188.81%-109.35%
Earnings Yield-51.25%-43.36%-66.44%-130.01%-14.97%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.000.100.110.060.09
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle0.00-3556.75-3475.81-6552.76-4239.84
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding0.003556.753475.816552.764239.84
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-1.29-1.53-2.32-5.86-7.92
Free Cash Flow Per Share-1.29-1.53-2.32-5.86-7.93
Dividend Paid and CapEx Coverage Ratio0.000.00-2212138.53-2171.02-2223.39
Capital Expenditure Coverage Ratio0.000.00-2212138.53-2171.02-2223.39
Operating Cash Flow Coverage Ratio0.00-246.15-70.24-647.13-137.58
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-52.23%-34.37%-52.65%-91.01%-15.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-1.94-2.31-1.51-0.77-6.68
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio1.137.181.791.446.82
Price-to-Free Cash Flow (P/FCF) Ratio-1.91-2.91-1.90-1.10-6.52
Price-to-Operating Cash Flow Ratio-1.91-2.91-1.90-1.10-6.52
Price-to-Earnings Growth (PEG) Ratio0.060.070.02-0.09-0.14
Enterprise Value Multiple-0.46-2.21-0.90-0.37-6.15
Enterprise Value3.23M13.21M7.34M6.43M81.37M
EV to EBITDA-0.46-2.21-0.90-0.37-6.15
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow-0.44-2.70-1.11-0.52-5.95
EV to Operating Cash Flow-0.44-2.70-1.11-0.52-5.95
Tangible Book Value Per Share1.85-0.031.703.396.19
Shareholders’ Equity Per Share2.190.622.474.487.57
Tax and Other Ratios
Effective Tax Rate-0.00-0.00-0.00-0.00-0.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-1.27-1.93-2.93-8.37-7.74
Tax Burden1.001.001.001.001.00
Interest Burden1.001.001.001.001.00
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality1.020.790.790.701.02

Currency in USD